Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Content uniformity testing for stratified samples via parametric tolerance interval testing.

Steven Novick1, Buffy Hudson-Curtis2

  • 1a Director, Statistical Sciences , MedImmune, Gaithersburg , MD , USA.

Journal of Biopharmaceutical Statistics
|April 20, 2017
PubMed
Summary

The parametric tolerance interval test (PTI-TOST) is enhanced to accurately assess drug content uniformity by accounting for batch location variations. This new method improves variability assessment, ensuring more reliable drug quality control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality by Design for Preclinical In Vitro Assay Development.

Pharmaceutical statistics·2024
Same author

Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assays.

Journal of biopharmaceutical statistics·2024
Same author

Hit screening with multivariate robust outlier detection.

PloS one·2024
Same author

Strategy for Designing In Vivo Dose-Response Comparison Studies.

Pharmaceutical statistics·2024
Same author

Peptide set test: a peptide-centric strategy to infer differentially expressed proteins.

Bioinformatics (Oxford, England)·2024
Same author

Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3.

ACS chemical biology·2024

Area of Science:

  • Pharmaceutical Sciences
  • Biostatistics
  • Drug Manufacturing

Background:

  • Traditional methods like USP<905> assess drug content uniformity.
  • Parametric tolerance interval test (PTI-TOST) offers an alternative for content uniformity.
  • Standard PTI-TOST assumes independent and identically distributed data, potentially overlooking batch location effects.

Purpose of the Study:

  • To introduce a modified two-tiered PTI-TOST that incorporates both between-location and within-location variance components.
  • To address the underestimation of total variability caused by location-specific correlations in traditional PTI-TOST.
  • To provide a statistically robust method for evaluating content uniformity in biopharmaceutical batches with potential location effects.

Main Methods:

Keywords:
Generalized pivotal quantityPTI-TOSTUSP<905>

Related Experiment Videos

  • Development of a two-tiered PTI-TOST model accounting for stratified sampling.
  • Inclusion of between-location and within-location variance components in the statistical model.
  • Generation of operating characteristic curves to guide practical application.

    • Main Results:

    • The proposed method accurately models variability by considering location effects.
    • Traditional PTI-TOST can underestimate variability when location differences exist.
    • The enhanced PTI-TOST provides a more reliable assessment of content uniformity.

    Conclusions:

    • The novel two-tiered PTI-TOST effectively addresses intra-batch location variability.
    • This method enhances the accuracy of content uniformity testing in biopharmaceutical manufacturing.
    • The study offers practical guidance for implementing this improved statistical approach.